Related Experiment Video
Updated: Sep 14, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Clinical Characteristics and Predictive Factors Analysis of Mycoplasma Pneumoniae Pneumonia Complicated with Pleural
Lianlian Ji1, Liqun Lin2, Jian Ye3
1Department of Pediatrics, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, Zhejiang, China. 15868714301@163.com.
Abstract:
Mycoplasma pneumoniae pneumonia (MPP) is a prevalent cause of respiratory infections in children, sometimes leading to pleural effusion (PE). This study aimed to identify risk factors and clinical features associated with PE in pediatric MPP patients. We conducted a retrospective case-control study involving 412 children with MPP and 82 with MPP+PE at the Third Affiliated Hospital of Wenzhou Medical University from January 2021 to January 2024. Demographic, clinical, and laboratory data were analyzed using multivariate logistic regression and receiver operating characteristic (ROC) curves. Significant findings included a higher incidence of immunocompromised states in the MPP+PE group (18.29% vs. 8.98%). At admission, children with MPP+PE exhibited higher respiratory rates (29.94 vs. 29.16 breaths/min), lower oxygen saturation (82.33% vs. 83.14%), longer fever duration (5.75 vs. 4.83 days), elevated white blood cell counts (WBC) (11.64×10^9/L vs. 10.12×10^9/L), and increased erythrocyte sedimentation rates (ESR) (20.66 vs. 19.49 mm/h). Patients with PE also experienced longer antibiotic treatment (9.14±4.91 vs. 7.46±3.29 days) and extended hospital stays (13.58±4.18 vs. 12.37±3.52 days). Multivariate analysis identified several significant predictors of PE, and a joint prediction model achieved an area under the curve (AUC) of 0.842, sensitivity of 0.796, and specificity of 0.793. These findings suggest that specific clinical and laboratory factors can help identify children at higher risk for PE, facilitating timely interventions.
Insights
Identifying children with Mycoplasma pneumoniae pneumonia (MPP) who may develop pleural effusion (PE) is crucial. This study found that immunocompromised status, higher respiratory rates, and elevated inflammatory markers predict PE in pediatric MPP patients.
Area of Science:
- Pediatric Respiratory Medicine
- Infectious Diseases
- Critical Care
Background:
- Mycoplasma pneumoniae pneumonia (MPP) is a common childhood respiratory illness.
- Pleural effusion (PE) is a potential complication of MPP, requiring specific management.
- Identifying risk factors for PE in pediatric MPP is essential for early intervention.
Purpose of the Study:
- To identify clinical and laboratory risk factors for developing pleural effusion in children with Mycoplasma pneumoniae pneumonia.
- To develop a predictive model for pleural effusion in pediatric MPP patients.
Main Methods:
- Retrospective case-control study of 412 children with MPP and 82 with MPP and PE.
- Analysis of demographic, clinical, and laboratory data.
- Multivariate logistic regression and ROC curve analysis were employed.
Main Results:
- Immunocompromised states were more frequent in the MPP+PE group (18.29% vs. 8.98%).
- Children with PE had higher respiratory rates, lower oxygen saturation, longer fever duration, elevated WBC and ESR at admission.
- The predictive model for PE demonstrated good performance with an AUC of 0.842.
Conclusions:
- Specific clinical and laboratory findings at admission can identify pediatric MPP patients at higher risk for pleural effusion.
- Early identification of high-risk children facilitates timely intervention and management of MPP with PE.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Related Concept Videos
Pneumonia III: Complications and Assessment
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...